Purchases and Sales Made in Q3 2022 in Edesa Biotech, Inc. (EDSA)
This table provides information about the institutional ownership of Edesa Biotech, Inc. (EDSA) during Q3 2022. The information is specifically focused on institutions that hold shares of Edesa Biotech, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 04, 2022
Q3 2022
|
Cm Management, LLC
|
BUY
|
- |
250KNew |
$348K - $2.49M
|
250K
$618K
|
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
8.6K+ 245.08% |
$12K - $85.5K
|
12.1K
$29.9K
|
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
4+ 5.63% |
$5.56 - $39.8
|
75
$185
|
|
|
Nov 14, 2022
Q3 2022
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
4+ 3.85% |
$5.56 - $39.8
|
108
$267
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
SELL
|
- |
-1.07K- 97.0% |
$1.48K - $10.6K
|
33
$81.5
|
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-35.9K- 66.73% |
$49.9K - $357K
|
17.9K
$44.2K
|